SOGROYA
Active substance: somapacitan
INJECTION, SOLUTION · SOMAPACITAN 6.7 mg/mL
United StatesActive
Marketing holder: Novo Nordisk
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SOMAPACITAN · 6.7 mg/mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-5c3b-765c-99f5-9f748b16615e,01a1208d-18d4-7716-83d8-16d1170e8fba,01a12098-6eea-7781-babb-722710d51409;count=3 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0169-2030
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 0169-2030 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0169-2030 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0169-2030 · Verified 2026-10-09 · open in source